Bristol-Myers Squibb Company
Pharmaceuticals
Company Summary
The Bristol-Myers Squibb Company is a global biopharmaceutical company that discovers, develops, licences, manufactures, and markets biopharmaceutical products. It sells medicines for haematology, cancer, cardiology, immunology, fibrosis, neurology, and covid-19. The company's headquarters are in New York, where it was founded in 1887.
Website : https://www.bms.com/
ESG Rating Overview
Sustainalytics
Overall ESG Rating :
22.7
Rating Scale
0-10Negligible10-20Low20-30Med30-40High40+Severe
Refinitiv
Overall ESG Rating :
83
Rating Scale
0-25Poor 25-50Satisfactory 50-75Good75-100Excellent
MSCI
Overall ESG Rating :
A
Rating Scale
CCCB
Laggard
BBBBBA
Average
AAAAA
Leader
BMS is average among 76 companies in the pharmaceuticals industry.
Temperature Rise :
1.6℃
CLIMATE SCALE
≥ 3.85°CLagging > 2°C - < 3.85°CMisaligned ≤ 2°CAligned
